Artemis Medicare Services Ltd Shows Signs of Mild Bullish Momentum Amid Mixed Technical Signals

Technical Trend Shift and Price Momentum

On 10 Feb 2026, Artemis Medicare’s stock closed at ₹228.00, marking a 4.97% increase from the previous close of ₹217.20. The intraday range saw a low of ₹217.60 and a high of ₹229.35, indicating a strong upward price momentum within the day. This price movement reflects a mild bullish trend after a period of sideways consolidation, signalling potential renewed investor interest.

Over the past week, however, the stock has underperformed the broader market, with a 1W return of -4.76% compared to the Sensex’s 2.94% gain. The one-month and year-to-date returns remain negative at -11.71% and -15.87% respectively, while the one-year return lags significantly at -19.66% against the Sensex’s 7.97%. Despite these short-term setbacks, Artemis Medicare’s long-term performance remains impressive, with a three-year return of 233.82% and a five-year return exceeding 1000%, far outpacing the Sensex’s respective 38.25% and 63.78% gains.

MACD and RSI: Divergent Signals

The Moving Average Convergence Divergence (MACD) indicator presents a nuanced picture. On a weekly basis, the MACD remains bearish, suggesting that momentum has not fully shifted to the upside. The monthly MACD is mildly bearish, indicating that while some downward pressure persists, it is less pronounced than before. This divergence between weekly and monthly MACD readings highlights the transitional phase the stock is currently undergoing.

Conversely, the Relative Strength Index (RSI) offers a more optimistic outlook. Both weekly and monthly RSI readings are bullish, signalling that buying momentum is gaining traction. The RSI’s improvement suggests that the stock is moving away from oversold conditions and may be poised for further gains if this momentum sustains.

Bollinger Bands and Moving Averages: Mixed Technical Landscape

Bollinger Bands on the weekly chart remain mildly bearish, indicating that price volatility is somewhat constrained and the stock is yet to break decisively above resistance levels. On the monthly timeframe, the bands suggest a sideways trend, reinforcing the notion of consolidation rather than a clear directional move.

Daily moving averages, however, have turned mildly bullish, with the stock price trading above key short-term averages. This shift suggests that recent buying interest is gaining momentum and could support further upward price movement if sustained. The interplay between these indicators points to a cautious but improving technical environment.

Additional Technical Indicators and Market Context

The Know Sure Thing (KST) oscillator remains mildly bearish on both weekly and monthly charts, signalling that momentum is not yet fully confirmed on the upside. Dow Theory analysis shows no clear trend on the weekly scale and a mildly bearish stance monthly, reflecting the stock’s current indecisiveness in broader market cycles.

On-Balance Volume (OBV) readings align with this view, showing no trend weekly and mildly bearish monthly, suggesting that volume flows have not decisively supported the recent price gains. These mixed signals highlight the importance of monitoring volume and momentum indicators closely in the coming sessions.

Valuation and Market Capitalisation Insights

Artemis Medicare Services Ltd holds a Market Cap Grade of 3, indicating a mid-tier market capitalisation relative to its peers in the hospital sector. The company’s Mojo Score has improved to 64.0, resulting in an upgrade from a previous Sell rating to a Hold as of 09 Feb 2026. This upgrade reflects the technical parameter changes and a more favourable risk-reward profile based on current momentum and valuation metrics.

Investors should note that while the stock’s short-term returns have lagged the Sensex, its long-term outperformance remains compelling. The 52-week high of ₹305.95 and low of ₹208.75 provide a wide trading range, with the current price of ₹228.00 closer to the lower end, potentially offering value for investors with a medium to long-term horizon.

Investor Takeaway and Outlook

Artemis Medicare Services Ltd’s recent technical parameter changes suggest a cautious shift towards a mildly bullish momentum, supported by improving RSI and daily moving averages. However, the persistence of bearish signals in MACD, KST, and OBV on weekly and monthly timeframes advises prudence.

For investors, this mixed technical landscape means that while the stock shows potential for recovery and upward movement, confirmation through sustained volume and momentum is essential before committing significant capital. The upgrade to a Hold rating by MarketsMOJO reflects this balanced view, recognising the stock’s improving technical profile without signalling a definitive buy opportunity yet.

Comparatively, Artemis Medicare’s long-term returns remain robust, underscoring the company’s strong fundamentals and growth prospects within the hospital sector. Investors with a longer investment horizon may find value in accumulating shares at current levels, especially if the stock breaks above key resistance points and technical indicators align more favourably.

Monitoring the interplay of MACD, RSI, Bollinger Bands, and moving averages in the coming weeks will be critical to gauge whether Artemis Medicare can sustain its momentum and transition into a stronger bullish phase.

Unlock special upgrade rates for a limited period. Start Saving Now →